Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms
Related Experiment Video
Updated: Dec 9, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Joe Taylor1, Alison M Yeomans1, Graham Packham1
1Cancer Research UK Centre, Cancer Sciences, Faculty of Medicine, University of Southampton, SO16 6YD Southampton, United Kingdom.
Abstract:
Cancer development is frequently associated with dysregulation of mRNA translation to enhance both increased global protein synthesis and translation of specific mRNAs encoding oncoproteins. Thus, targeted inhibition of mRNA translation is viewed as a promising new approach for cancer therapy. In this article we review current progress in investigating dysregulation of mRNA translation initiation in mature B-cell neoplasms, focusing on chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma. We discuss mechanisms and regulation of mRNA translation, potential pathways by which genetic alterations and the tumor microenvironment alters mRNA translation in malignant B cells, preclinical evaluation of drugs targeted against specific eukaryotic initiation factors and current progress towards clinical development. Overall, inhibition of mRNA translation initiation factors is an exciting and promising area for development of novel targeted anti-tumor drugs.
Insights
Targeting mRNA translation, a key cancer cell process, offers a promising new therapy. Inhibiting translation initiation factors shows potential for novel anti-tumor drugs in mature B-cell neoplasms.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Cancer development involves dysregulated mRNA translation, increasing protein synthesis and oncoprotein production.
- Targeting mRNA translation presents a novel therapeutic strategy for cancer treatment.
- Mature B-cell neoplasms like CLL, FL, and DLBCL exhibit altered mRNA translation.
Purpose of the Study:
- To review the dysregulation of mRNA translation initiation in mature B-cell neoplasms.
- To explore mechanisms linking genetic alterations and the tumor microenvironment to altered mRNA translation.
- To summarize preclinical and clinical progress of drugs targeting translation initiation factors.
Main Methods:
- Review of current literature on mRNA translation regulation in cancer.
- Analysis of mechanisms of mRNA translation dysregulation in B-cell malignancies.
- Evaluation of preclinical data for drugs targeting eukaryotic initiation factors.
Main Results:
- Dysregulation of mRNA translation is a hallmark of cancer, particularly in mature B-cell neoplasms.
- Genetic alterations and the tumor microenvironment significantly impact mRNA translation in malignant B cells.
- Preclinical studies demonstrate the efficacy of targeting eukaryotic initiation factors.
Conclusions:
- Inhibition of mRNA translation initiation factors is a promising strategy for novel targeted cancer therapies.
- Further clinical development of these targeted agents is warranted for B-cell malignancies.
- Understanding translation regulation provides new avenues for anti-cancer drug discovery.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
07:56Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
Published on: August 18, 2010
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Experimental RNAi
MicroRNAs
MicroRNAs
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...